These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 15637132

  • 1. Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism.
    Nojima J, Kuratsune H, Suehisa E, Iwatani Y, Kanakura Y.
    Clin Chem; 2005 Mar; 51(3):545-52. PubMed ID: 15637132
    [Abstract] [Full Text] [Related]

  • 2. Strong correlation between the prevalence of cerebral infarction and the presence of anti-cardiolipin/beta2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies--Co-existence of these antibodies enhances ADP-induced platelet activation in vitro.
    Nojima J, Kuratsune H, Suehisa E, Kitani T, Iwatani Y, Kanakura Y.
    Thromb Haemost; 2004 May; 91(5):967-76. PubMed ID: 15116258
    [Abstract] [Full Text] [Related]

  • 3. Acquired activated protein C resistance is associated with the co-existence of anti-prothrombin antibodies and lupus anticoagulant activity in patients with systemic lupus erythematosus.
    Nojima J, Kuratsune H, Suehisa E, Kawasaki T, Machii T, Kitani T, Iwatani Y, Kanakura Y.
    Br J Haematol; 2002 Aug; 118(2):577-83. PubMed ID: 12139749
    [Abstract] [Full Text] [Related]

  • 4. Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages.
    Bizzaro N, Tonutti E, Villalta D, Tampoia M, Tozzoli R.
    Arch Pathol Lab Med; 2005 Jan; 129(1):61-8. PubMed ID: 15628909
    [Abstract] [Full Text] [Related]

  • 5. [Advanced clinical laboratory studies in the graduate school of medicine--studies on pathogenic mechanisms of anti-phospholipid syndrome].
    Nojima J.
    Rinsho Byori; 2009 Aug; 57(8):786-92. PubMed ID: 19764414
    [Abstract] [Full Text] [Related]

  • 6. Anti-prothrombin antibodies combined with lupus anti-coagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus.
    Nojima J, Kuratsune H, Suehisa E, Futsukaichi Y, Yamanishi H, Machii T, Kitani T, Iwatani Y, Kanakura Y.
    Br J Haematol; 2001 Sep; 114(3):647-54. PubMed ID: 11552993
    [Abstract] [Full Text] [Related]

  • 7. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus.
    Nojima J, Iwatani Y, Suehisa E, Kuratsune H, Kanakura Y.
    Haematologica; 2006 May; 91(5):699-702. PubMed ID: 16627257
    [Abstract] [Full Text] [Related]

  • 8. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β2 -Glycoprotein I Domain I and Anti-Phosphatidylserine/Prothrombin Complex Antibodies Tests.
    Nakamura H, Oku K, Amengual O, Ohmura K, Fujieda Y, Kato M, Bohgaki T, Yasuda S, Atsumi T.
    Arthritis Care Res (Hoboken); 2018 Apr; 70(4):627-634. PubMed ID: 28686816
    [Abstract] [Full Text] [Related]

  • 9. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 10. High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa.
    Kawakami T, Yamazaki M, Mizoguchi M, Soma Y.
    Arthritis Rheum; 2007 Dec 15; 57(8):1507-13. PubMed ID: 18050170
    [Abstract] [Full Text] [Related]

  • 11. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME, Cabiedes J, Reyes E, Cabral AR.
    Rev Invest Clin; 2005 Dec 15; 57(4):563-71. PubMed ID: 16315641
    [Abstract] [Full Text] [Related]

  • 12. Coexistence of anti-β2-glycoprotein I domain I and anti-phosphatidylserine/prothrombin antibodies suggests strong thrombotic risk.
    Lee JS, Gu J, Park HS, Yoo HJ, Kim HK.
    Clin Chem Lab Med; 2017 May 01; 55(6):882-889. PubMed ID: 28002027
    [Abstract] [Full Text] [Related]

  • 13. Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15-year longitudinal study.
    Bizzaro N, Ghirardello A, Zampieri S, Iaccarino L, Tozzoli R, Ruffatti A, Villalta D, Tonutti E, Doria A.
    J Thromb Haemost; 2007 Jun 01; 5(6):1158-64. PubMed ID: 17388963
    [Abstract] [Full Text] [Related]

  • 14. Acquired activated protein C resistance is associated with IgG antibodies to protein S in patients with systemic lupus erythematosus.
    Nojima J, Iwatani Y, Ichihara K, Tsuneoka H, Ishikawa T, Yanagihara M, Takano T, Hidaka Y.
    Thromb Res; 2009 May 01; 124(1):127-31. PubMed ID: 19128822
    [Abstract] [Full Text] [Related]

  • 15. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM, Thiagarajan P, Ahn C, Reveille JD, Tinker KF, Arnett FC.
    J Rheumatol; 1998 Apr 01; 25(4):667-74. PubMed ID: 9558167
    [Abstract] [Full Text] [Related]

  • 16. [Antiphospholipid syndrome and stroke].
    Kitagawa Y.
    Rinsho Shinkeigaku; 2005 Nov 01; 45(11):852-5. PubMed ID: 16447744
    [Abstract] [Full Text] [Related]

  • 17. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O, Crippa L, Della Valle P, Sabbadini MG, Viganò D'Angelo S, D'Angelo A.
    Haematologica; 1999 Sep 01; 84(9):829-38. PubMed ID: 10477458
    [Abstract] [Full Text] [Related]

  • 18. Anti-beta2-glycoprotein I (GPI) autoantibodies, annexin V binding and the anti-phospholipid syndrome.
    Hanly JG, Smith SA.
    Clin Exp Immunol; 2000 Jun 01; 120(3):537-43. PubMed ID: 10844535
    [Abstract] [Full Text] [Related]

  • 19. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis.
    Ishikura K, Wada H, Kamikura Y, Hattori K, Fukuzawa T, Yamada N, Nakamura M, Nobori T, Nakano T.
    Am J Hematol; 2004 Aug 01; 76(4):338-42. PubMed ID: 15282665
    [Abstract] [Full Text] [Related]

  • 20. Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus.
    Nojima J, Masuda Y, Iwatani Y, Kuratsune H, Watanabe Y, Suehisa E, Takano T, Hidaka Y, Kanakura Y.
    Rheumatology (Oxford); 2008 May 01; 47(5):684-9. PubMed ID: 18375400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.